Related Experiment Videos
Rhinocerebral mucormycosis: an unusual case presentation
A K Bhattacharyya1, A R Deshpande, S R Nayak
1Department of Otorhinolaryngology, K.E.M. Hospital, Parel, Bombay, India.
Abstract:
Rhinocerebral mucormycosis is a rapidly fatal fungal disease which involves the nose, paranasal sinuses, orbit and central nervous system. The fungal infection is usually secondary to immunosuppression, diabetic acidosis, or antibiotic, steroid or cytotoxic therapy. It can also occur in patients suffering from burns, malignancy and haematological disorders. Current treatment consists of correction of the underlying disorder, repeated debridement of the wound in combination with intravenous amphotericin B. This paper describes our experience with a case of rhinocerebral mucormycosis. This is an unusual case in which mucormycosis was seen in a young female where no underlying cause was found. She responded to surgical debridement in combination with intravenous amphotericin B.
Insights
Rhinocerebral mucormycosis, a severe fungal infection, can be fatal. This case highlights successful treatment with surgery and amphotericin B in a young female with no apparent underlying cause.
Area of Science:
- Medicine
- Mycology
- Infectious Diseases
Background:
- Rhinocerebral mucormycosis is a life-threatening fungal infection affecting the nose, sinuses, orbit, and CNS.
- It typically occurs secondary to immunosuppression, diabetic ketoacidosis, or certain therapies.
Observation:
- This report details a rare instance of rhinocerebral mucormycosis in a young female.
- Notably, no predisposing underlying condition was identified in this patient.
Findings:
- The patient received surgical debridement combined with intravenous amphotericin B.
- This treatment regimen led to a positive response and recovery.
Implications:
- This case suggests that rhinocerebral mucormycosis can occur without identifiable risk factors.
- Aggressive surgical intervention and antifungal therapy remain crucial for managing this severe infection.